Discover
BLFS
BioLife Solutions, Inc.
28.49
2 x 20.65
2 x 36.16
bid
ask
+
0.25
0.89%
2 @ 04:00 PM
28.49 +0.00 (0.00%)
| Ytd | 17.82% | |
| 1y | 31.53% |
28.16
day range
28.95
17.86
52 week range
30.00
| Open | 28.25 | Prev Close | 28.24 | Low | 28.16 | High | 28.95 | Mkt Cap | 1.39B |
| Vol | 778.50K | Avg Vol | 715.47K | EPS | -0.24 | P/E | N/A | Forward P/E | 86.33 |
| Beta | 1.97 | Short Ratio | 4.46 | Inst. Own | 104.44% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 24.29 | 200-d Avg | 24.01 | 1yr Est | 32.11 |
| Income Statement | |||
| Total Revenue | 27.50M | ||
| Revenues (USD) | 27.50M | ||
| Cost of Revenue | 10.00M | ||
| Gross Profit | 17.50M | ||
| Operating Expenses | 17.47M | ||
| Research and Development Expense | 2.65M | ||
| Selling, General and Administrative Expense | 14.73M | ||
| Operating Income | 27.00K | ||
| Interest Expense | -1.04M | ||
| Income Tax Expense | 62.00K | ||
| Net Income | 1.19M | ||
| Net Income Common Stock | 1.19M | ||
| Net Income Common Stock (USD) | 1.19M | ||
| Consolidated Income | 1.19M | ||
| Earnings per Basic Share | 0.02 | ||
| Earnings per Basic Share (USD) | 0.02 | ||
| Earnings per Diluted Share | 0.02 | ||
| Earning Before Interest & Taxes (EBIT) | 207.00K | ||
| Earning Before Interest & Taxes (USD) | 207.00K | ||
| Weighted Average Shares | 48.46M | ||
| Weighted Average Shares Diluted | 49.25M | ||
| Balance Sheet | |||
| Cash and Equivalents | 22.82M | ||
| Cash and Equivalents (USD) | 22.82M | ||
| Investments | 88.67M | ||
| Investments Current | 58.17M | ||
| Investments Non-Current | 30.50M | ||
| Trade and Non-Trade Receivables | 13.06M | ||
| Current Assets | 133.22M | ||
| Property, Plant & Equipment Net | 21.62M | ||
| Total Assets | 400.91M | ||
| Debt Current | 4.82M | ||
| Total Debt | 14.86M | ||
| Current Liabilities | 18.25M | ||
| Debt Non-Current | 10.04M | ||
| Total Liabilities | 28.68M | ||
| Accumulated Retained Earnings (Deficit) | -338.51M | ||
| Accumulated Other Comprehensive Income | -120.00K | ||
| Shareholders Equity | 372.23M | ||
| Shareholders Equity (USD) | 372.23M | ||
| Assets Non-Current | 267.68M | ||
| Total Debt (USD) | 14.86M | ||
| Goodwill and Intangible Assets | 212.52M | ||
| Inventory | 32.83M | ||
| Liabilities Non-Current | 10.42M | ||
| Trade and Non-Trade Payables | 3.75M | ||
| Tax Liabilities | 2.31M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 699.00K | ||
| Net Cash Flow from Financing | -7.89M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.22M | ||
| Capital Expenditure | -167.00K | ||
| Issuance (Purchase) of Equity Shares | 190.00K | ||
| Issuance (Repayment) of Debt Securities | -2.50M | ||
| Net Cash Flow from Investing | -1.83M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -1.66M | ||
| Net Cash Flow from Operations | -491.00K | ||
| Share Based Compensation | 4.81M | ||